FIELD: medicine.
SUBSTANCE: claimed agent contains 2.2 % of ionol oily solution. Agent of present invention makes it possible to stabilize and reduce to increase content of reduced glutathione, to prevent oxidation of reduced protein thiol groups and to reduce capacities of eye-lens antioxidant protection. Application of iodinol solution prevents depletion of glutathione-peroxidase activity maintaining enzyme activity at high level, increases glutathione-8H-transferase activity, etc.
EFFECT: agent for stabilization and regression of cataract.
5 tbl
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION FOR CATARACT TREATMENT | 2005 |
|
RU2298408C2 |
EYE DROPS FOR TREATING AGE-RELATED NUCLEAR CATARACT | 2019 |
|
RU2720676C2 |
NEW EYE DROPLETS FOR CONSERVATIVE TREATMENT AND PREVENTION OF THE AGE-RELATED NUCLEAR CATARACT | 2015 |
|
RU2637875C2 |
EYE DROPS | 2009 |
|
RU2404768C1 |
METHOD OF CONSERVATIVE TREATMENT AND PREVENTION OF CORTICAL TYPE OF AGE CATARACT | 2009 |
|
RU2418568C2 |
IMPROVED EYE DROPS FOR PREVENTION AND TREATMENT OF EARLY MANIFESTATIONS OF AGE-RELATED NUCLEAR CATARACT | 2020 |
|
RU2748598C1 |
PHARMACEUTICAL COMPOSITION CONTAINING AZAPENTACENE (VERSIONS) | 2014 |
|
RU2571279C1 |
METHOD OF CONSERVATIVE TREATMENT AND PREVENTION OF NUCLEAR TYPE OF AGE CATARACT | 2009 |
|
RU2411926C2 |
METHOD OF TREATING EYE DISEASES ACCOMPANIED BY OXIDATIVE STRESS | 2014 |
|
RU2577236C1 |
METHOD OF TREATING EXPERIMENTAL CHEMICAL BURNS AND CATARACTS MODELED ON CHINCHILLAS RABBITS | 2019 |
|
RU2711543C1 |
Authors
Dates
2007-04-20—Published
2005-02-21—Filed